F. Saad, “Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone”, CUAJ, vol. 10, no. 3-4, pp. 102–9, Apr. 2016.